Publicaties

 

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.

Alma Hoxhaj A, Drissen MMCM, Vos JR, Bult P, Mann RM, Hoogerbrugge N.

Cancer 2022. htps://doi.org/10.1002/cncr.34326

 

Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM, Vos JR, van der Biessen-van Beek DTJ, van der Post RS, Nagtegaal ID, van Kouwen MCA, Bisseling TM, Hoogerbrugge N. 

Cancers. 2022;14(16):4005. PMID: 36010998

 

Catch them if you are aware: PTEN postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour Syndrome and literature review.
Hendricks LAJ, Schuurs-Hoeijmakers J, Spier I, Haadsma ML, Eijkelenboom A, Cremer K, Mensenkamp AR, Aretz S, Vos JR, Hoogerbrugge N. 
Eur J Med Genet. 2022;65(7):104533. PMID: 35640862
 
Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM, Schieving JH, Schuurs-Hoeijmakers JHM, Vos JR, Hoogerbrugge N. 
Eur J Med Genet. 2021;64(12):104364. PMID: 34637944
 

A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
Hendricks LAJ, Hoogerbrugge N, Schuurs-Hoeijmakers JHM, Vos JR. 

Clin Genet. 2021;99:219-225. PMID: 33140411

 

“Patient Journeys”: improving care by patient involvement.

Bolz-Johnson M, Meek J, Hoogerbrugge N.

Eur J Hum Genet. 2020;28(2):141-143. PMID: 31801983

 

Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.

Jonker LA, Lebbink CA, Jongmans MCJ, Nievelstein RAJ, Merks JHM, Nieveen van Dijkum EJM, Links TP, Hoogerbrugge N, van Trotsenburg ASP, van Santen HM.
Eur Thyroid J. 2020;9(5):234-242.PMID: 33088791
 

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome.

Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N; PHTS Guideline Development Group; European Reference Network GENTURIS.
Eur J Hum Genet. 2020;28(10):1387-1393. PMID: 32533092
 

Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.

Sloot YJE, Rabold K, Netea MG, Smit JWA, Hoogerbrugge N, Netea-Maier RT.
Oncogene. 2019;38(19):3743-3755. PMID: 30670777

nl_NL_formalNL